Development of an LC-MS Method for Measuring TNF in Human Vaginal Tissue

被引:11
|
作者
Choi, S. O.
Rezk, N. [1 ]
Kim, J. S. [1 ]
Kashuba, A. D. M. [1 ]
机构
[1] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; TENOFOVIR; ASSAY;
D O I
10.1093/chromsci/48.3.219
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive, accurate, and precise liquid chromatography-mass spectrometry assay for the determination of tenofovir (TNF) in human vaginal tissue was developed and validated. After homogenization of the tissue, solid-phase extraction on Varian Bond Elut-C-18 column was used for sample clean up. Chromatographic separation of TNF and the internal standard (tolbutamide) was achieved with a Varian Polaris 3C(18)-A reversed-phase analytical column (1150 mm x 2 mm). A gradient method using 0.1% formic acid in water and 0.1% formic acid in acetonitrile was employed. Detection of TNF and tolbutamide was achieved by electrospray ionization mass spectrometry in the positive ion mode using 288.05 and 271.00 m/z, respectively. Linear TNF calibration curves were obtained between 1-1,000 ng/mL with a correlation coefficient (r(2)) greater than 0.999. Intra- and inter-day accuracy for TNF ranged from 89.7% and 109.4% and from 97.3% and 104.9%, and precision ranged from 1.3% and 10.9% and 2.6% and 9.0%, respectively. This is the first validated method developed to quantitate TNF in human tissues.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 50 条
  • [31] Development and application of an LC-MS/MS method for measuring the effect of (partial) agonists on cAMP accumulation in vitro
    Goutier, W.
    Spaans, P. A.
    van der Neut, M. A. W.
    McCreary, A. C.
    Reinders, J. H.
    JOURNAL OF NEUROSCIENCE METHODS, 2010, 188 (01) : 24 - 31
  • [32] Development of an LC-MS/MS method for aromatase inhibitor screening
    Myeong Hyeon Park
    In Sook Kim
    Mi-Sook Dong
    Hye Hyun Yoo
    Analytical and Bioanalytical Chemistry, 2014, 406 : 3443 - 3449
  • [33] Development and validation of a LC-MS/MS method for salicylate analysis
    Yang, Lufang
    Rawluk, Cathy
    Ball, Gordon
    Hoag, Gordon
    CLINICAL BIOCHEMISTRY, 2016, 49 (18)
  • [34] Method development and validation of tranexamic acid by LC-MS/MS
    Ivica, Josko
    Gauthier, Jeannette
    Lamy, Andre
    Potter, Murray
    CLINICAL BIOCHEMISTRY, 2019, 74 : 90 - 90
  • [35] DEVELOPMENT OF LC-MS/MS REFERENCE METHOD FOR THE QUANTIFICATION OF LIPOPROTEIN(A)
    Marcovina, S. M.
    Vaisar, T.
    Clouet-Foraison, N.
    Hoofnagle, A.
    Koschinsky, M. L.
    Boffa, M. B.
    Lowenthal, M.
    ATHEROSCLEROSIS, 2021, 331 : E119 - E119
  • [36] Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine
    Huybrechts, B.
    Martins, J. C.
    Debongnie, Ph
    Uhlig, S.
    Callebaut, A.
    ARCHIVES OF TOXICOLOGY, 2015, 89 (11) : 1993 - 2005
  • [37] DEVELOPMENT OF A ONE MINUTE LC-MS/MS METHOD FOR IMMUNOSUPPRESANTS
    Probst, R.
    Hasenaecker, F.
    Lukacin, R.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S793 - S793
  • [38] Development of an LC-MS/MS method for aromatase inhibitor screening
    Park, Myeong Hyeon
    Kim, In Sook
    Dong, Mi-Sook
    Yoo, Hye Hyun
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (14) : 3443 - 3449
  • [39] LC-MS/MS Method for Probe Drugs in Human Plasma
    Reed, Gregory A.
    Gor, Parul
    Alnouti, Yazen
    FASEB JOURNAL, 2008, 22
  • [40] LC-MS/MS method for the determination of clodronate in human plasma
    Hasan, Mahmoud
    Schumacher, Gitta
    Seekamp, Anne
    Taedken, Tobias
    Siegmund, Werner
    Oswald, Stefan
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 100 : 341 - 347